REVIEW ARTICLE IMPURITY PROFILING OF DRUGS TOWARDS SAFETY AND EFFICACY: THEORY AND PRACTICE

被引:26
作者
Dhangar, Kiran R. [1 ]
Jagtap, Rakesh B. [1 ]
Surana, Sanjay J. [1 ]
Shirkhedkar, Atul A. [1 ]
机构
[1] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut Chem, Dhule 425405, MS, India
关键词
Impurity Profiling; Regulatory guidelines; Residual solvent; Genotoxicity; PERFORMANCE LIQUID-CHROMATOGRAPHY; FORCED DEGRADATION; CAPILLARY-ELECTROPHORESIS; HPLC METHOD; QUANTITATIVE-DETERMINATION; INTERNATIONAL-CONFERENCE; PHARMACEUTICAL PRODUCTS; STRUCTURE ELUCIDATION; GENOTOXIC IMPURITIES; ORGANIC IMPURITIES;
D O I
10.4067/S0717-97072017000200024
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Last decade has witnessed enormous changes in the studies of impurity profiling of drugs which can be reflected from pharmacopoeia and regulatory guidelines. The present review article is an attempt to provide comprehensive knowledge about various aspects and details about the impurity profiling in context with regulatory guidelines. Article also focused on isolation, separation and characterization techniques of impurities. It gives preliminary idea about applicability of virtual software used for studies on safety limit for impurities. The comprehensive information related to residual solvents, residual metals and genotoxicity studies of isolated impurities have also been incorporated into present article.
引用
收藏
页码:3543 / 3557
页数:15
相关论文
共 173 条
[1]  
Ahuja S., 2010, Handbook of Modern Pharmaceutical Analysis
[2]  
Ahuja S., 2011, CAPILLARY ELECTROPHO
[3]   Assuring quality of drugs by monitoring impurities [J].
Ahuja, Satinder .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (01) :3-11
[4]   Evaluation of mobile phase gradient supercritical fluid chromatography for impurity profiling of pharmaceutical compounds [J].
Alexander, A. J. ;
Hooker, T. F. ;
Tomasella, F. P. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 70 :77-86
[5]   Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 2: Safety Considerations of Impurities in Pharmaceutical Products and Surveying the Impurity Landscape [J].
Alsante, Karen M. ;
Huynh-Ba, Kim C. ;
Baertschi, Steven W. ;
Reed, Robert A. ;
Landis, Margaret S. ;
Furness, Scott ;
Olsen, Bernard ;
Mowery, Mark ;
Russo, Karen ;
Iser, Robert ;
Stephenson, Gregory A. ;
Jansen, Patrick .
AAPS PHARMSCITECH, 2014, 15 (01) :237-251
[6]   Pharmaceutical impurity identification: A case study using a multidisciplinary approach [J].
Alsante, KM ;
Boutros, P ;
Couturier, MA ;
Friedmann, RC ;
Harwood, JW ;
Horan, GJ ;
Jensen, AJ ;
Liu, QC ;
Lohr, LL ;
Morris, R ;
Raggon, JW ;
Reid, GL ;
Santafianos, DP ;
Sharp, TR ;
Tucker, JL ;
Wilcox, GE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (09) :2296-2309
[7]  
Anderson N.G., 2012, Practical Process Research Development, V2nd
[8]  
[Anonymous], 2004, ANAL INSTRUMENTATION
[9]  
[Anonymous], 2013, INT J PHARM RES
[10]  
[Anonymous], 2008, INT C HARM TECHN REQ, P1